(1) The Prescription Monitoring Program Prescribing Practices Review Subcommittee is established as a subcommittee of the Prescription Monitoring Program Advisory Commission created under ORS § 431A.890, for the purpose of advising the Oregon Health Authority and the commission on interpreting prescription information, understanding the clinical aspects of prescribing practices and evaluating prescribing practices.

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

(2)(a) The authority shall appoint the number of members to the subcommittee that the authority determines is necessary to fulfill the functions of the subcommittee.

(b) Members of the subcommittee must be practitioners who:

(A) Hold a valid license issued in this state or a valid emeritus license issued in this state;

(B) Are registered with the federal Drug Enforcement Administration to prescribe drugs classified in schedules II through IV; and

(C) Have at least five years of experience prescribing drugs classified in schedules II through IV.

(c) To the extent feasible, the authority shall appoint one member to the subcommittee for each type of practitioner in this state that prescribes drugs classified in schedules II through IV. [2017 c.683 § 20]

 

The amendments to 431A.896 by section 8, chapter 438, Oregon Laws 2023, become operative January 1, 2025, and apply to members appointed on or after January 1, 2025. See section 9, chapter 438, Oregon Laws 2023, as amended by section 9a, chapter 438, Oregon Laws 2023, and see section 10, chapter 438, Oregon Laws 2023. The text that is operative on and after January 1, 2025, is set forth for the user’s convenience.

 

(1) The Prescription Monitoring Program Prescribing Practices Review Subcommittee is established as a subcommittee of the Prescription Monitoring Program Advisory Commission created under ORS § 431A.890, for the purpose of advising the Oregon Health Authority and the commission on interpreting prescription information, understanding the clinical aspects of prescribing practices and evaluating prescribing practices.

(2)(a) The authority shall appoint the number of members to the subcommittee that the authority determines is necessary to fulfill the functions of the subcommittee.

(b) Members of the subcommittee must be practitioners who:

(A) Hold a valid license issued in this state or a valid emeritus license issued in this state;

(B) Are registered with the federal Drug Enforcement Administration to prescribe drugs classified in schedules II through V; and

(C) Have at least five years of experience prescribing drugs classified in schedules II through V.

(c) To the extent feasible, the authority shall appoint one member to the subcommittee for each type of practitioner in this state that prescribes drugs classified in schedules II through V.